Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 34Myeloid 34Lymphoid 26Classical hematology 21Plasma cell 18Sarcoma 15Dermatologic 9CNS 4Other neoplasm 2Gynecologic 2Genitourinary 2Breast 2Thoracic 1

Conditions

Thymoma 2Lung Neoplasms 2Myelodysplastic Syndromes 1Melanoma 1Leukemia 1Graft vs Host Disease 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Anemia, Refractory 1

Interventions

Azacitidine 4Nivolumab 2sargramostim 1ruxolitinib 1rucaparib 1incomplete Freund's adjuvant 1cc-486 1bemcentinib 1abiraterone 1Tretinoin 1TTI-621 1Standard of Care 1Rituximab 1Radiotherapy 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Palliative Care 1Paclitaxel 1Methylprednisolone 1Melphalan 1Injections 1Immunoenzyme Techniques 1INCB059872 1INCB057643 1Gemcitabine 1Flow Cytometry 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × Methylprednisolone × Thoracic × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡